SCA10 Archives - National Ataxia Foundation

Interrupciones en las repeticiones están asociadas con ataques epilépticos en SCA10

April 5, 2024

Escrito por Dr Hannah ShorrockEditado por Larissa NitschkeTraducido por Ismael Araujo-Aliaga Interrupciones en las repeticiones en SCA10 influyen en la estabilidad del tramo repetido y están asociadas con ataques epilépticos Múltiples ataxias espinocerebelosas (SCAs) son causadas por mutaciones de expansión de repeticiones, pero en algunos casos, estas expansiones se encuentran Read More…

Snapshot: What is Riluzole?

October 15, 2021

Riluzole, often sold under the trade name Rilutek, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). ALS is a fatal neurodegenerative disease that mainly affects neurons controlling muscle movements. The drug was approved by the FDA (1995), Health Canada (1997), and the European Commission (1996). It Read More…

Repeat interruptions are associated with epileptic seizures in SCA10

July 24, 2020

Written by Dr Hannah Shorrock Edited by Larissa Nitschke Repeat interruptions in SCA10 influence repeat tract stability and are associated with epileptic seizures Multiple spinocerebellar ataxias (SCAs) are caused by repeat expansion mutations, but in some cases, these repeat expansions are interrupted. The presence of repeat interruptions can influence disease Read More…

What is Ataxia?

Español

Educational Resources

Info by Ataxia Type

Info by Ataxia Type

Newly Diagnosed?

Find Healthcare

Treatment Development

Support Groups

Connect

NAF Resources

Other Resources

Healthcare Provider Resources

NAF Ataxia Research

NAF Funded Research by Year

Participate in Research

Learn About Research

Research Support

Drug Development Resources

Research Collaboration

Other Resources

Support NAF

Fundraise